Regulations, liability, safety, and economics related to compounding

Ethical issues of compounding cantharidin in dermatology

“…The US Pharmacopeia wrote guidelines for compounding pharmacies dispensing sterile and nonsterile drugs, mandating increased supervision of compounding in the office and pharmacy. 1 Currently, no Food and Drug Administration (FDA)-approved cantharidin formulation exists. It is considered a ''Bulk Drug Substance Under Evaluation'' by the FDA.…”